Category: Medications - Page 2

27Feb

REMS for Clozapine: What Changed in 2025 and How ANC Monitoring Works Now

Posted by Dorian Fitzwilliam 13 Comments

The FDA removed the mandatory REMS program for clozapine in February 2025. ANC monitoring is still recommended, but no longer tracked by federal systems. Learn how this change improves access and what patients and providers must do now.

21Feb

Immunosuppressants: Cyclosporine and Tacrolimus Generic Issues

Posted by Dorian Fitzwilliam 8 Comments

Cyclosporine and tacrolimus are critical for transplant patients, but generic versions can cause dangerous fluctuations in drug levels. Learn why switching generics isn't safe without careful monitoring and how to protect your transplant.

15Feb

Extended-Release vs. Immediate-Release Medications: Timing, Risks, and What You Need to Know

Posted by Dorian Fitzwilliam 10 Comments

Extended-release and immediate-release medications work differently, affecting how fast they act, how long they last, and their risks. Understanding the difference can prevent overdose, improve effectiveness, and save money.

13Feb

High-Dose Statins After Stroke: What You Need to Know About Benefits and Risks

Posted by Dorian Fitzwilliam 9 Comments

High-dose statins after stroke can cut recurrent stroke risk by 16%, but raise brain bleed risk. Learn who benefits, what side effects to watch for, and smarter alternatives in 2026.

7Feb

How to Store Prescription Labels and Leaflets for Future Reference

Posted by Dorian Fitzwilliam 11 Comments

Keep prescription labels and leaflets organized to prevent dangerous medication errors. Learn how to store them physically and digitally for long-term safety and peace of mind.

3Feb

Federal Circuit Court: Authority on Pharmaceutical Patent Cases

Posted by Dorian Fitzwilliam 11 Comments

The Federal Circuit Court holds exclusive authority over all U.S. pharmaceutical patent cases, shaping when generics enter the market, how patents are enforced, and how drug prices are affected. Its rulings on ANDA jurisdiction, dosing patents, and Orange Book listings have rewritten industry rules.

1Feb

Sulfonylureas and Weight Gain: What You Need to Know Long-Term

Posted by Dorian Fitzwilliam 11 Comments

Sulfonylureas lower blood sugar but often cause weight gain - up to 11 pounds in a year. Learn why this happens, which pills are worse, and how to fight back with smarter meds and lifestyle changes.

30Jan

Refrigerated Medications While Traveling: Best Cooling Options for Insulin, Biologics, and More

Posted by Dorian Fitzwilliam 13 Comments

Learn the best ways to keep insulin, Mounjaro, and other refrigerated medications at safe temperatures while traveling. Get real-world cooler comparisons, TSA tips, and expert-backed strategies to avoid dangerous temperature spikes.

21Jan

Doctor Attitudes Toward Generic Drugs: What Providers Really Think

Posted by Dorian Fitzwilliam 0 Comments

Many doctors still doubt generic drugs despite FDA approval and cost savings. This article explores why provider attitudes vary, what drives skepticism, and how education is changing prescribing habits.

20Jan

L-Tryptophan and Antidepressants: What You Need to Know About Serotonin Risks and Interactions

Posted by Dorian Fitzwilliam 10 Comments

L-Tryptophan boosts serotonin, but combining it with antidepressants like SSRIs can cause dangerous serotonin syndrome. Learn the real risks, clinical evidence, and safe practices.